JPRN-UMIN000022151已完成未知
The efficacy and safety of mefloquine in patients with progressive multifocal leukoencephalopathy - The efficacy and safety of mefloquine in patients with progressive multifocal leukoencephalopathy
Department of Neurology, Shimane University Hospital0 个研究点目标入组 5 人开始时间: 2016年4月30日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients with other infection of the central nervous system. 2) Physical status is severe or unstable. 3) Patients with severe psychiatric disorder. 4) Pregnant women or patients with possible pregnancy. 5) Patients with a history of hypersensitivity to this drug.
研究者
相似试验
Unknown
不适用
EVALUATION OF THE SAFETY AND EFFICACY OF MEFLOQUINE AS INTERMITTENT PREVENTIVE TREATMENT FOR MALARIA IN PREGNANCYMalariaPACTR2010020001429343FCRB
Unknown
不适用
EVALUATION OF THE SAFETY AND EFFICACY OF MEFLOQUINE AS INTERMITTENT PREVENTIVE TREATMENT FOR MALARIA IN PREGNANCY IN HIV+ PATIENTSHIV/AIDSPregnancy and ChildbirthMalariaPACTR2010020001813440FCRB
尚未招募
4 期
Evaluate the efficacy and safety of Artesunate-mefloquine (ASMQ) and low dose primaquine to treat uncomplicated Plasmodium falciparum and Plasmodium vivax malaria in Champasack province, Lao PDRMalariaACTRN12618001349235Ministry of Health120
尚未招募
4 期
Efficacy and safety of artesunate+mefloquine+primaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Tak, Ratchaburi, Ranong and Yala provinces in Thailandncomplicated falciparum malaria patientsUncomplicated falciparum malaria patientsInfection - Other infectious diseasesACTRN12610000553077Bureau of Vector-borne Disease300
暂停
4 期
Efficacy and safety of artesunate-mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria in Binh Phuoc and Dak Nong provinces, Viet Nam, in 2019.Patients infected Plasmodium falciparum malaria.Infection - Other infectious diseasesACTRN12620001375943World Health Organization84